Obesity Not Associated With Worse Long-Term TAR Outcomes
-
By
-
Kathryn Wighton
-
May 6, 2026
-
4 min
By
Kathryn Wighton
May 6, 2026
From Medicare payment updates to drug approvals and device access, these federal actions may affect reimbursement, prescribing, patient access, and clinical workflows.
July 10, 2026
Two single-injection cross-linked hyaluronic acid formulations showed no statistically significant advantage over saline for pain or functional outcomes through 24 weeks.
July 10, 2026
A structured overview of recent FDA recalls, corrections, and alerts involving medications, ventilators, insulin delivery systems, cardiovascular devices, anesthesia products, and other equipment used in clinical practice.
June 18, 2026